Regulatory Story
Go to market news section View chart   Print
RNS
Toumaz Limited  -  TMZ   

Total Voting Rights

Released 10:04 30-Nov-2012

RNS Number : 4203S
Toumaz Limited
30 November 2012
 



Toumaz Limited

 

("Toumaz" or the "Company")

 

Total Voting Rights

 

Toumaz Limited (AIM: TMZ), a pioneer in low cost, ultra-low power wireless communications technology, announces that the total number of ordinary shares of 0.25 pence each in the share capital of Toumaz in issue as at the date of this notice is 1,135,455,010  with each share carrying the right to one vote.

 

There are no shares held in treasury.  Therefore, the total number of voting rights in the Company is 1,135,455,010. The above figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company, under the FSA's Disclosure and Transparency Rules.

 

 

Enquiries

Toumaz Limited

Anthony Sethill, Chief Executive Officer

 

 

Peel Hunt LLP (Nominated Adviser and Broker)

 

 

+44 (0)1235 438950

 

 

 

+44 (0)20 7418 8900

Richard Kauffer/Daniel Harris




College Hill

+44 (0)20 7457 2020

Adrian Duffield/Rozi Morris


 

 

 

About Toumaz - (www.toumazltd.com)

 Toumaz is a pioneer in low cost, ultra-low power wireless technologies for a wide range of markets including medical monitoring and internet connected consumer devices. The recent acquisition of Frontier Silicon brings operational scale and expertise together with a leadership position in digital and networked audio markets.

The Group combines its strong IP and technology base with the commercial scale of Frontier to exploit two key wireless technology sectors:

 

Professional healthcare solutions

Consumer semiconductors in digital audio and sport & health markets

 

Toumaz's ultra-low power sensor platform, Sensium™, targets the professional healthcare market and is a leader in real-time wireless monitoring of the body's vital signs with the potential to transform medical monitoring and reduce the cost of healthcare. SensiumVitals is the Group's first product in this field. For healthcare professionals, this creates new opportunities for pro-active monitoring and improved quality of care. For patients, it delivers new opportunities for personalised healthcare.

 

Toumaz plans to transfer its Sensium™ technology to the consumer sports and health market, where its advanced measurement algorithms and low energy solutions give it a competitive advantage.

Toumaz is also using its expertise to design devices for wireless connectivity and internet-connected products. The acquisition of Frontier Silicon has enhanced the Group's technology portfolio in Network Audio and elevates Toumaz to a market leadership position in this and the digital radio markets. The Group now supplies multimedia/FM/DAB chips and modules to all major audio brands.

 

Toumaz is an AIM listed company (AIM: TMZ) with development centres in Oxford and Cambridge in the UK and in Hong Kong and in Shenzhen in the People's Republic of China. 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TVREAEFEDELAFFF
Close


London Stock Exchange plc is not responsible for and does not check content on this Website. Website users are responsible for checking content. Any news item (including any prospectus) which is addressed solely to the persons and countries specified therein should not be relied upon other than by such persons and/or outside the specified countries. Terms and conditions, including restrictions on use and distribution apply.

 


Total Voting Rights - RNS